ArticleJTO clinical and research reports2025

Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents.

Anne C Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.